Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study

[1]  Peter Bader,et al.  An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia , 2017, Clinical Cancer Research.

[2]  J. Wagner,et al.  Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  S. Nierkens,et al.  Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly. , 2017, Stem cell investigation.

[4]  C. van Kesteren,et al.  Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation. , 2016, Blood.

[5]  V. Rocha.  Umbilical cord blood cells from unrelated donor as an alternative source of hematopoietic stem cells for transplantation in children and adults. , 2016, Seminars in hematology.

[6]  W. Wood,et al.  Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  C. Craddock,et al.  Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols , 2016, British journal of haematology.

[8]  H. Einsele,et al.  Impact of Atg-containing Reduced-intensity Conditioning after Single-or Double-unit Allogeneic Cord Blood Transplantation on Behalf of Eurocord and the European Society for Blood and Marrow Transplantation Key Points , 2022 .

[9]  J. Kurtzberg,et al.  Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  Karl Frauendorfer,et al.  One million haemopoietic stem-cell transplants: a retrospective observational study. , 2015, The Lancet. Haematology.

[11]  D. Middleton,et al.  Determination of HLA‐A, ‐C, ‐B, ‐DRB1 allele and haplotype frequency in Japanese population based on family study , 2015, Tissue antigens.

[12]  J. Wagner,et al.  One-unit versus two-unit cord-blood transplantation for hematologic cancers. , 2014, The New England journal of medicine.

[13]  M. Horowitz,et al.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. , 2014, Blood.

[14]  J. Klein,et al.  Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. , 2014, Blood.

[15]  J. Wagner,et al.  Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  K. Ballen,et al.  Umbilical cord blood transplantation: the first 25 years and beyond. , 2013, Blood.

[17]  J. Ishikawa,et al.  Double-unit cord blood transplantation after myeloablative conditioning for patients with hematologic malignancies: a multicenter phase II study in Japan. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  J. Kanda,et al.  Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia , 2013, Haematologica.

[19]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[20]  J. Klein,et al.  Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. , 2011, The Lancet. Oncology.

[21]  L. Freedman,et al.  Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries , 2011, Bone Marrow Transplantation.

[22]  A. Scaradavou,et al.  Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. , 2010, Blood.

[23]  E. Gluckman,et al.  Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft‐ and transplantation‐related factors , 2009, British journal of haematology.

[24]  B. Sandmaier,et al.  Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  J. Wagner,et al.  Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. , 2006, Blood.

[26]  J. Fay,et al.  Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. , 2005, Blood.

[27]  S. Asano,et al.  Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. , 2004, Blood.

[28]  T. Tarpey.  Self-Consistency and Principal Component Analysis , 1999 .

[29]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[30]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[31]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[32]  K. Sullivan,et al.  Chronic graft-versus-host disease and other late complications of bone marrow transplantation. , 1991, Seminars in hematology.

[33]  M. Tanimoto,et al.  Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group , 1989, Blood.

[34]  A. S. Wiener,et al.  Transplantation , 1963 .

[35]  T. Montgomery.  The umbilical cord. , 1960, Clinical obstetrics and gynecology.